Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$78.27 - $151.29 $6,261 - $12,103
-80 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$94.25 - $132.81 $377 - $531
-4 Reduced 4.76%
80 $7,000
Q4 2020

Jan 13, 2021

BUY
$102.03 - $184.62 $6,733 - $12,184
66 Added 366.67%
84 $10,000
Q3 2020

Nov 12, 2020

SELL
$93.53 - $163.34 $1,309 - $2,286
-14 Reduced 43.75%
18 $2,000
Q2 2020

Aug 13, 2020

BUY
$126.3 - $176.56 $4,041 - $5,649
32 New
32 $5,000

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.